Famitinib

CAS No. 945380-27-8

Famitinib( SHR 1020 )

Catalog No. M16770 CAS No. 945380-27-8

Famitinib (SHR1020) is a structural analogue of sunitinib, novel and potent multi-targeted RTK inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Famitinib
  • Note
    Research use only, not for human use.
  • Brief Description
    Famitinib (SHR1020) is a structural analogue of sunitinib, novel and potent multi-targeted RTK inhibitor.
  • Description
    Famitinib (SHR1020) is a structural analogue of sunitinib, novel and potent multi-targeted RTK inhibitor, including c-Kit, VEGFR2/3, PDGFRβ, FLT-1/3 receptor and c-RET; demonstrates the higher potency in tumour growth inhibition in human tumour xenograft models compared with sunitinib.Colon Cancer Phase 3 Clinical.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SHR 1020
  • Pathway
    Angiogenesis
  • Target
    c-Kit
  • Recptor
    c-Kit
  • Research Area
    Cancer
  • Indication
    Colon Cancer

Chemical Information

  • CAS Number
    945380-27-8
  • Formula Weight
    410.493
  • Molecular Formula
    C23H27FN4O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCN(CC)CCN1CCC2=C(C1=O)C(=C(N2)C=C3C4=C(C=CC(=C4)F)NC3=O)C
  • Chemical Name
    (Z)-5-(2-(diethylamino)ethyl)-2-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-3-methyl-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Xie C, et al. Br J Pharmacol. 2013 Apr;168(7):1687-706. 2. Zhang W, et al. Chin Med J (Engl). 2013 Nov;126(22):4277-81. 3. Zhou A, et al. Cancer Chemother Pharmacol. 2013 Nov;72(5):1043-53. 4. Ge S, et al. Oncol Lett. 2016 Sep;12(3):1763-1768.
molnova catalog
related products
  • RGB-286638 free base

    RGB-286638 free base is a novel CDK inhibitor.

  • Famitinib

    Famitinib (SHR1020) is a structural analogue of sunitinib, novel and potent multi-targeted RTK inhibitor.

  • AZD3229

    AZD3229 (AZD-3229) is a potent, pan-KIT mutant inhibitor with potent single digit nM growth inhibition against a diverse panel of mutant KIT driven Ba/F3 cell lines (GI50=1-50 nM).